-
OHR Pharmaceutical Gains 7% Following Agreement With FDA
Tuesday, March 29, 2016 - 9:05am | 190Shares of OHR Pharmaceutical Inc (NASDAQ: OHRP), a nano-cap pharmaceutical company that focuses on the treatment of ocular diseases, spiked higher by more than 7 percent early Tuesday morning. OHR Pharmaceutical announced it has reached an agreement on the Special Protocol Assessment (SPA) with the...